Genentec, OSI Pharma to pay $67M to resolve Tarceva false claims
Tuesday, June 7, 2016 - 15:30
in Mathematics & Economics
Allen ConeSAN FRANCISCO, D.C., June 7 (UPI) -- Pharmaceutical firms Genentech Inc. and OSI Pharmaceuticals LLC will pay $67 million to settle False Claims Act allegations involving cancer drug Tarceva.